SRPT logo

Sarepta Therapeutics, Inc. (SRPT) Retained Earnings

Annual Retained Earnings:

-$4.21B+$235.24M(+5.29%)
December 31, 2024

Summary

  • As of today, SRPT annual retained earnings is -$4.21 billion, with the most recent change of +$235.24 million (+5.29%) on December 31, 2024.
  • During the last 3 years, SRPT annual retained earnings has fallen by -$1.00 billion (-31.32%).
  • SRPT annual retained earnings is now -33859.47% below its all-time high of -$12.40 million, reached on December 31, 1996.

Performance

SRPT Retained Earnings Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherSRPTbalance sheet metrics

Quarterly Retained Earnings:

-$4.64B-$179.95M(-4.03%)
September 30, 2025

Summary

  • As of today, SRPT quarterly retained earnings is -$4.64 billion, with the most recent change of -$179.95 million (-4.03%) on September 30, 2025.
  • Over the past year, SRPT quarterly retained earnings has dropped by -$271.51 million (-6.21%).
  • SRPT quarterly retained earnings is now -35604.13% below its all-time high of -$13.00 million, reached on March 31, 1997.

Performance

SRPT Quarterly Retained Earnings Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherSRPTbalance sheet metrics

Retained Earnings Formula

Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid

SRPT Retained Earnings Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1Y1 Year+5.3%-6.2%
3Y3 Years-31.3%-22.1%
5Y5 Years-83.6%-74.6%

SRPT Retained Earnings Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs Low
3Y3-Year-31.3%+5.3%-22.1%+0.4%
5Y5-Year-83.6%+5.3%-74.6%+0.4%
All-TimeAll-Time>-9999.0%+5.3%>-9999.0%+0.4%

SRPT Retained Earnings History

DateAnnualQuarterly
Sep 2025
-
-$4.64B(-4.0%)
Jun 2025
-
-$4.46B(+4.2%)
Mar 2025
-
-$4.66B(-10.6%)
Dec 2024
-$4.21B(+5.3%)
-$4.21B(+3.6%)
Sep 2024
-
-$4.37B(+0.8%)
Jun 2024
-
-$4.40B(+0.1%)
Mar 2024
-
-$4.41B(+0.8%)
Dec 2023
-$4.45B(-13.7%)
-$4.45B(+1.0%)
Sep 2023
-
-$4.49B(-0.9%)
Jun 2023
-
-$4.45B(-0.5%)
Mar 2023
-
-$4.43B(-13.2%)
Dec 2022
-$3.91B(-21.9%)
-$3.91B(-2.9%)
Sep 2022
-
-$3.80B(-7.3%)
Jun 2022
-
-$3.54B(-7.0%)
Mar 2022
-
-$3.31B(-3.3%)
Dec 2021
-$3.21B(-12.6%)
-$3.21B(-4.0%)
Sep 2021
-
-$3.08B(-1.6%)
Jun 2021
-
-$3.04B(-2.8%)
Mar 2021
-
-$2.96B(-3.8%)
Dec 2020
-$2.85B(-24.2%)
-$2.85B(-7.1%)
Sep 2020
-
-$2.66B(-8.0%)
Jun 2020
-
-$2.46B(-6.5%)
Mar 2020
-
-$2.31B(-0.8%)
Dec 2019
-$2.29B(-45.3%)
-$2.29B(-11.5%)
Sep 2019
-
-$2.06B(-6.5%)
Jun 2019
-
-$1.93B(-16.7%)
Mar 2019
-
-$1.66B(-4.9%)
Dec 2018
-$1.58B(-29.7%)
-$1.58B(-9.8%)
Sep 2018
-
-$1.44B(-5.6%)
Jun 2018
-
-$1.36B(-8.7%)
Mar 2018
-
-$1.25B(-2.9%)
Dec 2017
-$1.22B(-4.3%)
-$1.22B(-2.0%)
Sep 2017
-
-$1.19B(-4.2%)
Jun 2017
-
-$1.15B(-5.8%)
Mar 2017
-
-$1.08B(+7.2%)
Dec 2016
-$1.17B(-29.7%)
-$1.17B(-8.2%)
Sep 2016
-
-$1.08B(-5.6%)
Jun 2016
-
-$1.02B(-6.5%)
Mar 2016
-
-$958.83M(-6.6%)
Dec 2015
-$899.05M(-32.4%)
-$899.05M(-7.8%)
Sep 2015
-
-$834.37M(-6.6%)
Jun 2015
-
-$782.43M(-5.7%)
Mar 2015
-
-$740.58M(-9.1%)
Dec 2014
-$679.02M(-25.0%)
-$679.02M(-7.0%)
Sep 2014
-
-$634.61M(-4.8%)
Jun 2014
-
-$605.38M(-5.9%)
Mar 2014
-
-$571.51M(-5.2%)
Dec 2013
-$543.24M(-26.0%)
-$543.24M(-1.7%)
Sep 2013
-
-$534.42M(-8.5%)
Jun 2013
-
-$492.39M(-4.0%)
Mar 2013
-
-$473.33M(-9.8%)
Dec 2012
-$431.25M(-39.1%)
-$431.25M(-16.8%)
Sep 2012
-
-$369.18M(-15.5%)
Jun 2012
-
-$319.63M(+2.5%)
Mar 2012
-
-$327.67M(-5.7%)
Dec 2011
-$309.96M
-$309.96M(-0.5%)
Sep 2011
-
-$308.55M(-1.3%)
Jun 2011
-
-$304.53M(+0.4%)
DateAnnualQuarterly
Mar 2011
-
-$305.81M(+0.6%)
Dec 2010
-$307.65M(-11.7%)
-$307.65M(-2.5%)
Sep 2010
-
-$300.00M(-2.5%)
Jun 2010
-
-$292.71M(-6.0%)
Mar 2010
-
-$276.05M(-0.2%)
Dec 2009
-$275.47M(-10.1%)
-$275.47M(+1.3%)
Sep 2009
-
-$278.99M(-3.0%)
Jun 2009
-
-$270.90M(-7.8%)
Mar 2009
-
-$251.24M(-0.4%)
Dec 2008
-$250.31M(-10.6%)
-$250.31M(-0.5%)
Sep 2008
-
-$249.17M(-2.5%)
Jun 2008
-
-$243.12M(-0.7%)
Mar 2008
-
-$241.37M(-6.6%)
Dec 2007
-$226.36M(-11.1%)
-$226.36M(-1.9%)
Sep 2007
-
-$222.23M(-0.1%)
Jun 2007
-
-$221.98M(-4.0%)
Mar 2007
-
-$213.44M(-4.8%)
Dec 2006
-$203.72M(-18.0%)
-$203.72M(-4.3%)
Sep 2006
-
-$195.39M(-3.6%)
Jun 2006
-
-$188.61M(-3.8%)
Mar 2006
-
-$181.71M(-5.2%)
Dec 2005
-$172.65M(-10.7%)
-$172.65M(-2.7%)
Sep 2005
-
-$168.10M(-1.0%)
Jun 2005
-
-$166.40M(-3.1%)
Mar 2005
-
-$161.47M(-3.5%)
Dec 2004
-$155.97M(-18.9%)
-$155.97M(-3.3%)
Sep 2004
-
-$150.98M(-3.5%)
Jun 2004
-
-$145.88M(-5.2%)
Mar 2004
-
-$138.73M(-5.7%)
Dec 2003
-$131.19M(-12.5%)
-$131.19M(-2.4%)
Sep 2003
-
-$128.10M(-3.7%)
Jun 2003
-
-$123.50M(-2.9%)
Mar 2003
-
-$120.00M(-2.9%)
Dec 2002
-$116.58M(-33.7%)
-$116.58M(-3.5%)
Sep 2002
-
-$112.58M(-6.7%)
Jun 2002
-
-$105.53M(-11.0%)
Mar 2002
-
-$95.03M(-9.0%)
Dec 2001
-$87.22M(-44.7%)
-$87.22M(-5.6%)
Sep 2001
-
-$82.61M(-23.3%)
Jun 2001
-
-$67.02M(-5.6%)
Mar 2001
-
-$63.47M(-5.3%)
Dec 2000
-$60.29M(-18.0%)
-$60.29M(-5.3%)
Sep 2000
-
-$57.29M(-4.1%)
Jun 2000
-
-$55.03M(-5.4%)
Mar 2000
-
-$52.19M(-2.2%)
Dec 1999
-$51.10M(-19.4%)
-$51.05M(-4.8%)
Sep 1999
-
-$48.72M(-4.7%)
Jun 1999
-
-$46.51M(-4.5%)
Mar 1999
-
-$44.51M(-4.1%)
Dec 1998
-$42.80M(-167.5%)
-$42.78M(-5.9%)
Sep 1998
-
-$40.38M(-111.1%)
Jun 1998
-
-$19.13M(-9.5%)
Mar 1998
-
-$17.47M(-9.2%)
Dec 1997
-$16.00M(-29.0%)
-$16.00M(-5.3%)
Sep 1997
-
-$15.20M(-6.3%)
Jun 1997
-
-$14.30M(-10.0%)
Mar 1997
-
-$13.00M
Dec 1996
-$12.40M
-

FAQ

  • What is Sarepta Therapeutics, Inc. annual retained earnings?
  • What is the all-time high annual retained earnings for Sarepta Therapeutics, Inc.?
  • What is Sarepta Therapeutics, Inc. annual retained earnings year-on-year change?
  • What is Sarepta Therapeutics, Inc. quarterly retained earnings?
  • What is the all-time high quarterly retained earnings for Sarepta Therapeutics, Inc.?
  • What is Sarepta Therapeutics, Inc. quarterly retained earnings year-on-year change?

What is Sarepta Therapeutics, Inc. annual retained earnings?

The current annual retained earnings of SRPT is -$4.21B

What is the all-time high annual retained earnings for Sarepta Therapeutics, Inc.?

Sarepta Therapeutics, Inc. all-time high annual retained earnings is -$12.40M

What is Sarepta Therapeutics, Inc. annual retained earnings year-on-year change?

Over the past year, SRPT annual retained earnings has changed by +$235.24M (+5.29%)

What is Sarepta Therapeutics, Inc. quarterly retained earnings?

The current quarterly retained earnings of SRPT is -$4.64B

What is the all-time high quarterly retained earnings for Sarepta Therapeutics, Inc.?

Sarepta Therapeutics, Inc. all-time high quarterly retained earnings is -$13.00M

What is Sarepta Therapeutics, Inc. quarterly retained earnings year-on-year change?

Over the past year, SRPT quarterly retained earnings has changed by -$271.51M (-6.21%)
On this page